Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Dose Daily News Bureau
facebook
instagram
linkedin
Exclusive Content
Lupin Partners with Spektus Pharma to Commercialise Novel Antidepressant in Canada
Dose daily
Dose Daily News Bureau
-
February 18, 2026
FSSAI Says Preventive Healthcare to Drive India’s Nutraceutical Boom Beyond Pharma
Dose daily
Dose Daily News Bureau
-
February 17, 2026
Bengal Expands Oncology Network with Two New Specialised Treatment Centres
Dose daily
Dose Daily News Bureau
-
February 16, 2026
Government Clarifies: No Revision in Cardiac Stent Price Limits
Dose daily
Dose Daily News Bureau
-
February 14, 2026
UGC Equity Regulations 2026 Face Judicial Halt After Widespread Protests
Dose daily
Dose Daily News Bureau
-
February 13, 2026
FDA Cracks Down on Misleading Pharma Advertising, Flags Novo’s Obesity Pill Ad
Dose daily
Dose Daily News Bureau
-
February 11, 2026
cc
1
...
23
24
25
...
41
Page 24 of 41
I want in
I've read and accept the
Privacy Policy
.
ICMR & NCDC Supports Kerala in Managing Nipah Case
Dose Daily News Bureau
-
June 15, 2026
FSSAI Bans Use of Metallic Pins and Wires in Food Packaging
Breaking News
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Breaking News
Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order
Breaking News
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
Breaking News
The FDA has outlined its updated strategy for generic drug oversight
Breaking News
×